Acute activation of the calcium-sensing receptor inhibits plasma renin activity in vivo

被引:43
作者
Atchison, Douglas K. [1 ,2 ]
Ortiz-Capisano, Cecilia [1 ]
Beierwaltes, William H. [1 ,2 ]
机构
[1] Henry Ford Hosp, Dept Internal Med, Hypertens & Vasc Res Div, Detroit, MI 48202 USA
[2] Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA
基金
美国国家卫生研究院;
关键词
blood pressure; parathyroid; calcimimetic; JUXTAGLOMERULAR CELLS; PARATHYROID-HORMONE; ADENYLYL-CYCLASE; BLOOD-PRESSURE; RELEASE; RATS; EXPRESSION; SECRETION; HYPERPARATHYROIDISM;
D O I
10.1152/ajpregu.00238.2010
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Atchison DK, Ortiz-Capisano MC, Beierwaltes WH. Acute activation of the calcium-sensing receptor inhibits plasma renin activity in vivo. Am J Physiol Regul Integr Comp Physiol 299: R1020-R1026, 2010. First published July 21, 2010; doi:10.1152/ajpregu.00238.2010.-In vitro, the renin-secreting juxtaglomerular cells express the calcium-sensing receptor, and its activation with the calcimimetic cinacalcet inhibits renin release. To test whether the activation of calcium-sensing receptor similarly inhibits plasma renin activity (PRA) in vivo, we hypothesized that the calcium-sensing receptor is expressed in juxtaglomerular cells in vivo, and acutely administered cinacalcet would inhibit renin activity in anesthetized rats. Since cinacalcet inhibits parathyroid hormone, which may stimulate renin activity, we sought to determine whether cinacalcet inhibits renin activity by decreasing parathyroid hormone. Lastly, we hypothesized that chronically administered cinacalcet would inhibit basal and stimulated renin in conscious rats. Calcium-sensing receptors and renin were localized in the same juxtaglomerular cells using immunofluorescence in rat cortical slices fixed in vivo. Cinacalcet was administered acutely via intravenous bolus in anesthetized rats and chronically in conscious rats by oral gavage. Acute administration of cinacalcet decreased basal renin activity from 13.6 +/- 2.4 to 6.1 +/- 1.1 ng ANG I.ml(-1).h(-1) (P < 0.001). Likewise, cinacalcet decreased furosemide-stimulated renin from 30.6 +/- 2.3 to 21.3 +/- 2.3 ng ANG I.ml-1.h(-1) (P < 0.001). In parathyroidectomized rats, cinacalcet decreased renin activity from 9.3 +/- 1.3 to 5.2 +/- 0.5 ng ANG I.ml(-1).h(-1) (P < 0.05) similar to sham-operated controls (13.5 +/- 2.2 to 6.6 +/- 0.8 ng ANG I.ml(-1).h(-1), P < 0.05). Chronic administration of cinacalcet over 7 days had no significant effect on PRA under basal or stimulated conditions. In conclusion, calcium-sensing receptors are expressed in juxtaglomerular cells in vivo, and acute activation of these receptors with cinacalcet inhibits PRA in anesthetized rats, independent of parathyroid hormone.
引用
收藏
页码:R1020 / R1026
页数:7
相关论文
共 27 条
  • [21] Decreased intracellular calcium stimulates renin release via calcium-inhibitable adenylyl cyclase
    Ortiz-Capisano, M. Cecilia
    Ortiz, Pablo A.
    Harding, Pamela
    Garvin, Jeffrey L.
    Beierwaltes, William H.
    [J]. HYPERTENSION, 2007, 49 (01) : 162 - 169
  • [22] Calcium-dependent phosphodiesterase 1C inhibits renin release from isolated juxtaglomerular cells
    Ortiz-Capisano, M. Cecilia
    Liao, Tang-Dong
    Ortiz, Pablo A.
    Beierwaltes, William H.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2009, 297 (05) : R1469 - R1476
  • [23] ANESTHETICS AND RENIN-ANGIOTENSIN-ALDOSTERONE AXIS
    PETTINGER, WA
    [J]. ANESTHESIOLOGY, 1978, 48 (06) : 393 - 396
  • [24] CLONING AND FUNCTIONAL EXPRESSION OF A RAT-KIDNEY EXTRACELLULAR CALCIUM POLYVALENT CATION-SENSING RECEPTOR
    RICCARDI, D
    PARK, J
    LEE, WS
    GAMBA, G
    BROWN, EM
    HEBERT, SC
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (01) : 131 - 135
  • [25] Rostaing L, 1997, CLIN NEPHROL, V47, P248
  • [26] EFFECT OF PARATHYROID-HORMONE ON PLASMA-RENIN ACTIVITY AND SODIUM-EXCRETION
    SMITH, JM
    MOUW, DR
    VANDER, AJ
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1979, 236 (03): : F311 - F319
  • [27] STRIBRNA IS, 1993, CAS LEK CESK, V132, P45